Clinical Trial Update: Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating olaparib as salvage therapy for cisplatin-resistant germ cell tumors has completed, assessing safety and preliminary efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor

Drugs mentioned

• Olaparib (Olaparib)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Neoplasms, Germ Cell and Embryonal | Phase 2 | Status: COMPLETED